(Q44539666)

English

SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist. II: Behavioral profile predictive of an atypical antipsychotic activity

scientific article published in November 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist. II: Behavioral profile predictive of an atypical antipsychotic activity (English)

1 reference

Europe PubMed Central

4 December 2017

author name string

Ronan Depoortere

1

1 reference

Europe PubMed Central

4 December 2017

Denis Boulay

2

1 reference

Europe PubMed Central

4 December 2017

Ghislaine Perrault

3

1 reference

Europe PubMed Central

4 December 2017

Olivier Bergis

4

1 reference

Europe PubMed Central

4 December 2017

Michel Decobert

5

1 reference

Europe PubMed Central

4 December 2017

Dominique Françon

6

1 reference

Europe PubMed Central

4 December 2017

Mireille Jung

7

1 reference

Europe PubMed Central

4 December 2017

Jacques Simiand

8

1 reference

Europe PubMed Central

4 December 2017

Philippe Soubrié

9

1 reference

Europe PubMed Central

4 December 2017

Bernard Scatton

10

1 reference

Europe PubMed Central

4 December 2017

language of work or name

0 references

publication date

1 November 2003

1 reference

Europe PubMed Central

4 December 2017

Neuropsychopharmacology

1 reference

Europe PubMed Central

4 December 2017

28

1 reference

Europe PubMed Central

4 December 2017

11

1 reference

Europe PubMed Central

4 December 2017

1889-1902

1 reference

Europe PubMed Central

4 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300261

0 references

Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

Do animal models of anxiety predict anxiolytic-like effects of antidepressants?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

Effect of metergoline, fenfluramine, and 8-OHDPAT on catalepsy induced by haloperidol or morphine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

Schizophrenics kill themselves too: a review of risk factors for suicide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

Barriers to progress--the impact of tolerability problems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist. I: Neurochemical and electrophysiological profile.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

Reversal of haloperidol-induced extrapyramidal side effects in cebus monkeys by 8-hydroxy-2-(di-n-propylamino)tetralin and its enantiomers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

5-HT1A receptor agonists: recent developments and controversial issues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

The serotonin syndrome and its treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

Working memory dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

The enhancement by lithium of the 5-HT1A mediated serotonin syndrome produced by 8-OH-DPAT in the rat: evidence for a post-synaptic mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

5-HT2 antagonism and EPS benefits: is there a causal connection?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

Behavioral aspects of serotonin-dopamine interaction in the monkey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

Effects of 5-HT1A agonists and 5-HT2 antagonists on haloperidol-induced dyskinesias in squirrel monkeys: no evidence for reciprocal 5-HT-dopamine interaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

The role of serotonin in antipsychotic drug action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

Reduction of guinea pig pup isolation calls by anxiolytic and antidepressant drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

Effects of dopamine antagonists in a two-way active avoidance procedure in rats: interactions with 8-OH-DPAT, ritanserin, and prazosin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

Risk factors for suicide in psychiatric patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

Inhibition of REM sleep by fluoxetine, a specific inhibitor of serotonin uptake

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

Differential effect of antipsychotics on place navigation of rats in the Morris water maze. A comparative study between novel and reference antipsychotics.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

Effect of adjunctive treatment with serotonin-1A agonist tandospirone on memory functions in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

Effect of tandospirone on tardive dyskinesia and parkinsonian symptoms.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

21 January 2018

Relationship of the use of adjunctive pharmacological agents to symptoms and level of function in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

7 January 2021

based on heuristic

inferred from DOI database lookup

On the mode of action of apomorphine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

7 January 2021

based on heuristic

inferred from DOI database lookup

Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

7 January 2021

based on heuristic

inferred from DOI database lookup

5-HT1A receptors in lithium-induced conditioned taste aversion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300261

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1300261

0 references

1 reference

Europe PubMed Central

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44539666&oldid=2098894376"